Clinical Trial Update: Hepatic Arterial Infusion (HAI) of Abraxane [Phase 1]

View source ↗

Summary

A Phase 1 study of hepatic arterial infusion of Abraxane for liver cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Liver Cancer, Advanced Cancers | Phase 1 | Status: COMPLETED